Werbung
Werbung
SNTI
Senti Biosciences, Inc. Common Stock
1.11
USDGesponsert
+0.03
+2.78%
09. Jan., 15:58 UTC -5
Geschlossen
Nach-Markt
1.13
+0.01
+1.35%
SNTI Ergebnisberichte
Positives Überraschungsverhältnis
SNTI übertreffen die 7 der letzten 8Schätzungen.
88%
Nächster Bericht
Datum des nächsten Berichts
18. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$680.00K
/-$0.42
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/-39.13%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-37.31%
Senti Biosciences, Inc. Common Stock earnings per share and revenue
On 13. Nov. 2025, SNTI reported earnings of -0.69 USD per share (EPS) for Q3 25, missing the estimate of -0.57 USD, resulting in a -19.38% surprise. Revenue reached --, compared to an expected 170.00 tausend, with a -100.00% difference. The market reacted with a -10.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.42 USD, with revenue projected to reach 680.00 tausend USD, implying an decrease of -39.13% EPS, and -- of --% in Revenue from the last quarter.
FAQ
What were Senti Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Senti Biosciences, Inc. Common Stock reported EPS of -$0.69, missing estimates by -19.38%, and revenue of $0.00, -100% below expectations.
How did the market react to Senti Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -10.06%, changed from $1.79 before the earnings release to $1.61 the day after.
When is Senti Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for 18. März 2026.
What are the forecasts for Senti Biosciences, Inc. Common Stock's next earnings report?
Based on 6
analysts, Senti Biosciences, Inc. Common Stock is expected to report EPS of -$0.42 and revenue of $680.00K for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung